We have been very bullish on Biovica. I wrote here several times about the opportunity, I published articles on SumZero and SeekingAlpha. We viewed the likelihood of the FDA approval for its Breast Cancer Test as over 90%. Market gave it much lower probability, the not patient retail sold the stock. Biovica got their FDAContinue reading “Biovica Invites to Market Update After its FDA Approval”
Arctic Securities Bullish Reports on Africa Oil and Africa Energy
Arctic on African Energy: “From waiting game to action time” Africa Energy and Africa Oil have a lot of catalysts in 2H22. The consensus is very bullish. Today Arctic joined the bullish analysts crowd on both stocks. Summary below. Africa Energy is our largest position in the sector, Africa Oil is the second largest. AfricaContinue reading “Arctic Securities Bullish Reports on Africa Oil and Africa Energy”
Sparebank Upgrades Mintra on Takeover Speculations
SpareBank published a new note on Mintra today, summarising their target price uplift. They argue that the two largest shareholders may buyout Mintra and take it private. The summary of the note is below. I never wrote here about Ocean GeoLoop, a novel carbon capture company. Our family office has a smaller position there. TheContinue reading “Sparebank Upgrades Mintra on Takeover Speculations”
SpareBank on Mintra – a highly potential public to private candidate
After the strongest quarter ever in Q1, Mintra reported another strong Q2 beat. Below is a summary of the broker reports. I wrote here about the investment case a few weeks ago. http://www.fitinvestmentideas.com/2022/07/15/mintra-smart-play-on-shipping-and-energy-exploration-boom/ We are long Mintra. Pareto Securities Report Q2 EBIT 34% ahead of expectationsMintra reports Q2 EBITDA of NOK 24m (22% ahead of PAS est.), EBIT of 18m (34% ahead ofContinue reading “SpareBank on Mintra – a highly potential public to private candidate”
Redeye Research on Sedana – a Novel ICU Sedation Company
We are long Sedana Medical a pioneer medtech and pharmaceutical company dedicated to making inhaled sedation a standard therapy in ICU (Intensive Care Unit). The company was the beneficiary in Covid, and a victim of post Covid sell off. We bought in believe that post Covid sell off was excessive. It is a smaller positionContinue reading “Redeye Research on Sedana – a Novel ICU Sedation Company”
Pareto Securities Monthly Portfolio Ideas for August
Every month Pareto Securities publishes their portfolio ideas for Norway and Sweden. They select ten stocks for each market. Below is our selection from that portfolio. Their Norwegian portfolio ideas outperformed the benchmark by 30%, Swedish portfolio by about 1%. I selected below the ideas we like most from the 20 stocks. We also publishedContinue reading “Pareto Securities Monthly Portfolio Ideas for August”
Quantafuel Dubai Announcement – Broker Comments
This morning, Quantafuel announced that they have signed a FEED agreement with DUBAL Holding and BASF for chemical recycling of waste plastics in Dubai. The project, consisting of an 80,000 tons per year facility, moves into the FEED stage after a six-month feasibility study, with a potential FID date targeted for early next year. PositiveContinue reading “Quantafuel Dubai Announcement – Broker Comments”
Our Top Ideas for Q3
We enclose our top ideas for Q3. I wrote her before about many of those and include links to the investment rationale. Biovica – FDA approved first biomarker test in cancer area On Monday Biovica reported FDA approval for its unique breast cancer test. The stock went up only by 30%. The current market capContinue reading “Our Top Ideas for Q3”
Broker Comments on Biovica Received FDA Approval for First Ever Biomarker in its Field
We have been very bullish on Biovica. I wrote here several times about the opportunity, I published articles on SumZero and SeekingAlpha. We viewed the likelihood of the FDA approval for its Breast Cancer Test as over 90%. Market gave it much lower probability, the not patient retail sold the stock. Over the weekend BiovicaContinue reading “Broker Comments on Biovica Received FDA Approval for First Ever Biomarker in its Field”
ABG Sundal Collier on Cool Company: Best Exposure to Appreciating LNG Spot Rates
We have been very bullish on Cool since the war started, I wrote here several times about the company. Thesis is simple. Europe is braking relience on Russian gas and will need to get gas from more remote places. By LNG tankers. Cool company should be one of the beneficients. Spot rates are booming, CoolContinue reading “ABG Sundal Collier on Cool Company: Best Exposure to Appreciating LNG Spot Rates”